Details for New Drug Application (NDA): 050571
✉ Email this page to a colleague
NDA 050571 describes CEFMAX, which is a drug marketed by Tap Pharm and is included in one NDA. Additional details are available on the CEFMAX profile page.
The generic ingredient in CEFMAX is cefmenoxime hydrochloride. There is one drug master file entry for this compound. Additional details are available on the cefmenoxime hydrochloride profile page.
The generic ingredient in CEFMAX is cefmenoxime hydrochloride. There is one drug master file entry for this compound. Additional details are available on the cefmenoxime hydrochloride profile page.
Summary for 050571
| Tradename: | CEFMAX |
| Applicant: | Tap Pharm |
| Ingredient: | cefmenoxime hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050571
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
| Approval Date: | Dec 30, 1987 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Dec 30, 1987 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Dec 30, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
